Uploaded July 2024 | Updated September 2026, 14 hours ago
Seminar Title: PennChart Genomics Initiative at Five Years: From Integration to Implementation
July 25, 2024 - Katherine (Kate) L. Nathanson, M.D., is the Pearl Basser Professor for BRCA-Related Research in the Department of Medicine, Division of Translational Medicine and Human Genetics, and Department of Genetics, at the Perelman School of Medicine of the University of Pennsylvania, Deputy Director of the Abramson Cancer Center, Director of the Penn Medicine Center for Genomic Medicine, and Director of Genetics for the Basser Center for BRCA. She is an internationally recognized for both her clinical and research expertise in cancer genetics/genomics.
Her research focuses on both inherited susceptibility to cancer and somatic genetic characterization of tumors, with interests across multiple tumor types, including testicular germ cell tumors, hereditary breast and ovarian cancers, melanoma and neuroendocrine tumors.
She has led studies leading to important insights in all these cancer types, playing critical roles in genotype-phenotype studies in multiple genes underlying hereditary breast and ovarian cancer, leading studies to understand the molecular features and immune profile of tumors associated with BRCA1/2 mutations, and the seminal studies elucidating genetic variation leading to testicular cancer susceptibility and the underlying disrupted pathways, as the leader of the Testicular Cancer Consortium (TECAC).
Dr. Nathanson has published over 400 peer-reviewed articles in journals such as Nature, JAMA, New England Journal of Medicine and Cancer Cell. Dr. Nathanson has an extensive record of national service, serving on committees for multiple organizations, such as ACMG and AACR, several editorial boards, and scientific review committees, and served as Chair of the Cancer Genetics study section for the National Institutes of Health. She has received multiple awards
The NHGRI Center for Precision Health Research (CPHR) sponsors a monthly series of talks by intramural and special guest speakers on research relevant to the use of genomic data and large-scale electronic health record information to improve health. Speakers are selected by CPHR faculty and cover research topics of interest to a wide audience.
Relevant Links:
CPHR Seminar Series: genome.gov/cphr/seminars
Nathanson Lab: https://www.med.upenn.edu/nathansonlab/
Seminar Title: PennChart Genomics Initiative at Five Years: From Integration to Implementation
July 25, 2024 - Katherine (Kate) L. Nathanson, M.D., is the Pearl Basser Professor for BRCA-Related Research in the Department of Medicine, Division of Translational Medicine and Human Genetics, and Department of Genetics, at the Perelman School of Medicine of the University of Pennsylvania, Deputy Director of the Abramson Cancer Center, Director of the Penn Medicine Center for Genomic Medicine, and Director of Genetics for the Basser Center for BRCA. She is an internationally recognized for both her clinical and research expertise in cancer genetics/genomics.
Her research focuses on both inherited susceptibility to cancer and somatic genetic characterization of tumors, with interests across multiple tumor types, including testicular germ cell tumors, hereditary breast and ovarian cancers, melanoma and neuroendocrine tumors.
She has led studies leading to important insights in all these cancer types, playing critical roles in genotype-phenotype studies in multiple genes underlying hereditary breast and ovarian cancer, leading studies to understand the molecular features and immune profile of tumors associated with BRCA1/2 mutations, and the seminal studies elucidating genetic variation leading to testicular cancer susceptibility and the underlying disrupted pathways, as the leader of the Testicular Cancer Consortium (TECAC).
Dr. Nathanson has published over 400 peer-reviewed articles in journals such as Nature, JAMA, New England Journal of Medicine and Cancer Cell. Dr. Nathanson has an extensive record of national service, serving on committees for multiple organizations, such as ACMG and AACR, several editorial boards, and scientific review committees, and served as Chair of the Cancer Genetics study section for the National Institutes of Health. She has received multiple awards
The NHGRI Center for Precision Health Research (CPHR) sponsors a monthly series of talks by intramural and special guest speakers on research relevant to the use of genomic data and large-scale electronic health record information to improve health. Speakers are selected by CPHR faculty and cover research topics of interest to a wide audience.
Relevant Links:
CPHR Seminar Series: genome.gov/cphr/seminars
Nathanson Lab: https://www.med.upenn.edu/nathansonlab/
